These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15777420)

  • 1. Partnerships between academic psychiatry and the pharmaceutical industry.
    Raven M; Rogers W; Jureidini J
    Australas Psychiatry; 2005 Mar; 13(1):83-4; author reply 84-6. PubMed ID: 15777420
    [No Abstract]   [Full Text] [Related]  

  • 2. Partnerships between academic psychiatry and the pharmaceutical industry: the Lilly MAP Initiative.
    Singh B; Copolov D; Grainger D; Goh J
    Australas Psychiatry; 2004 Sep; 12(3):220-4; discussion 225-6. PubMed ID: 15715778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborations between academic psychiatry and the pharmaceutical industry: a perspective from industry.
    Tohen M
    Epidemiol Psichiatr Soc; 2007; 16(3):197-8. PubMed ID: 18020191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the pharmaceutical industry in medical education in psychiatry.
    Lazarus A
    Acad Psychiatry; 2006; 30(1):40-4. PubMed ID: 16473993
    [No Abstract]   [Full Text] [Related]  

  • 5. Teaching trainees to negotiate research collaborations with industry: a mentorship model.
    Merrill DB; Girgis RR; Bickford LC; Vorel SR; Lieberman JA
    Am J Psychiatry; 2010 Apr; 167(4):381-6. PubMed ID: 20360328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.
    Chakrabarti A; Fleisher WP; Staley D; Calhoun L
    Ann R Coll Physicians Surg Can; 2002 Dec; 35(8 Suppl.):541-6. PubMed ID: 15015500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relations between academic departments of psychiatry and pharmaceutical companies.
    Jellinek M; Lazare A
    Am J Psychiatry; 1979 Jun; 136(6):827-9. PubMed ID: 443470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trainees and collaborations with industry.
    Brewer S
    Am J Psychiatry; 2010 Sep; 167(9):1127; author reply 1127. PubMed ID: 20826861
    [No Abstract]   [Full Text] [Related]  

  • 9. Industry has undue influence on academic collaboration and safeguards need strengthening: white coat… which hat.
    Harbin T
    Surv Ophthalmol; 2014; 59(3):346-8. PubMed ID: 24508214
    [No Abstract]   [Full Text] [Related]  

  • 10. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.
    Finkel AG
    Headache; 2006; 46(7):1181-5. PubMed ID: 16866722
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychiatric training program engagement with the pharmaceutical industry: an educational issue, not strictly an ethical one.
    Mohl PC
    Acad Psychiatry; 2005; 29(2):215-21. PubMed ID: 15937270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients expect transparency in doctors' relationships with the pharmaceutical industry. Comment.
    Dalton BS; Richards DJ
    Med J Aust; 2009 Apr; 190(8):460; author reply 460-1. PubMed ID: 19562859
    [No Abstract]   [Full Text] [Related]  

  • 13. New UK guidance on industry-health professional collaboration.
    Mintzes B
    BMJ; 2012 Jun; 344():e3952. PubMed ID: 22700788
    [No Abstract]   [Full Text] [Related]  

  • 14. The costs of vilifying pharma.
    Collier R
    CMAJ; 2015 Sep; 187(12):E369-70. PubMed ID: 26216615
    [No Abstract]   [Full Text] [Related]  

  • 15. Educational aspects of interactions with the pharmaceutical industry.
    Balon R
    Acad Psychiatry; 2010; 34(2):90-1. PubMed ID: 20224012
    [No Abstract]   [Full Text] [Related]  

  • 16. Key opinion leaders in psychiatry: a conflicted pathway to career advancement.
    Jureidini J
    Aust N Z J Psychiatry; 2012 Jun; 46(6):495-7. PubMed ID: 22679201
    [No Abstract]   [Full Text] [Related]  

  • 17. Key aspects of physician and pharmaceutical industry relationships for trainees.
    Jain S
    Acad Psychiatry; 2010; 34(2):98-101. PubMed ID: 20224015
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship of psychiatrists to the pharmaceutical companies--part of, or the solution to, the problem].
    Insel TR
    Lege Artis Med; 2010 Sep; 20(9):630-1. PubMed ID: 21469310
    [No Abstract]   [Full Text] [Related]  

  • 19. [Guidelines for cooperation between the child and adolescent psychiatry specialty, psychosomatic medicine and psychotherapy and the pharmaceutical industry].
    Lehmkuhl U;
    Z Kinder Jugendpsychiatr Psychother; 2006 Jul; 34(4):303-5. PubMed ID: 16927574
    [No Abstract]   [Full Text] [Related]  

  • 20. Co-opting psychiatry: the alliance between academic psychiatry and the pharmaceutical industry.
    Moncrieff J
    Epidemiol Psichiatr Soc; 2007; 16(3):192-6. PubMed ID: 18020190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.